The C57BL/6J-congenic CAG140 knock-in (CAG 140 KI) allele encodes the human HTT exon 1 sequence with ~140 repeats of a pure CAG tract replacing the mouse Htt exon 1. These B6J.CAG 140 KI mice may be useful for studying Huntington's disease.
Marie-Francoise Chesselet, University of California, Los Angeles
Dr. David Howland, CHDI Foundation
Stock No. 027409 was formerly associated with CHDI Foundation colony Stock No. 370625 [CHDI-81003002].
Huntington's disease (HD) is an autosomally dominant, fatal neurodegenerative disorder characterized by uncontrolled movements, psychiatric disturbances and cognitive impairment. HD is caused by an unstable trinucleotide (polyglutamine) repeat expansion in the huntingtin gene (HTT; HD or Hdh).
The CAG140 knock-in (CAG 140 KI) allele replaces mouse Htt exon 1 with the human HTT exon 1 sequence with ~140 repeats of a pure CAG tract [(CAG)nCAACAG, encoding polyglutamine (no arginine codon)]. The CAG repeat number is subject to germline and somatic instability, and may expand or contract. Mutant mice have mouse/human hybrid protein expression in cerebellum and forebrain at similar levels of endogenous protein. Homozygous and heterozygous mice are viable and fertile with normal lifespans. Homozygous mice may exhibit motor deficits (as evidenced in rotarod performance, gait/locomotion and exploratory behavior), with varying onset and severity depending on the protocols used. Homozygotes may have decreased body weight from 26 weeks of age. Heterozygous mice may exhibit relatively mild behavioral deficits with a late age of onset.
This Huntington's disease mouse model is available by way of a collaborative effort between CHDI Foundation, Dr. Marie-Francoise Chesselet (University of California, Los Angeles) and The Jackson Laboratory.
In these mutant mice, the CAG repeat number is subject to germline and somatic instability, and may expand or contract. When using lines with unstable CAG repeat length, it is strongly recommended the CAG repeat number be quantified in all the experimental animals; all animals in all experimental groups should carry comparable CAG repeat sizes. CAG repeat sizing of HD mice should be done using high-resolution methods as assays based on agarose gel electrophoresis typically do not provide sufficient resolution to accurately measure CAG repeat numbers. If labs do not have access to the appropriate equipment for determining CAG repeat length, CAG repeats can be evaluated on a fee-for-service basis by Laragen, Inc.
The CAG140 knock-in (CAG 140 KI) allele was designed by Dr. Marie-Francoise Chesselet (University of California, Los Angeles). A fragment extending from 18 bp upstream of the polyglutamine stretch in huntingtin (Htt; HD or Hdh) exon 1 to 100 bp into intron 1 was replaced with human HTT sequence containing 140 repeats of a pure CAG tract [(CAG)nCAACAG, encoding polyglutamine (no arginine codon)]. A floxed neo cassette was retained 1.3 kbp upstream of exon 1. The targeting vector was microinjected into 129S1/Sv-Oca2+ Tyr+ Kitl+-derived W9.5/W95 embryonic stem (ES) cells. The CAG 140 KI mice were backcrossed with C57BL/6J inbred mice (Stock No. 000664) at least four or five generations to create the C57BL/6J-congenic colony (B6J.CAG 140 KI), called CHDI Foundation colony Stock No. 370625 [CHDI-81003002]. In 2014, heterozygous animals with ~146 CAG repeat length were sent from the CHDI Foundation colony to The Jackson Laboratory Repository, from which B6J.CAG 140 KI heterozygotes are available as Stock No. 027409.
|Allele Name||targeted mutation 1, Marie-Francoise Chesselet|
|Allele Type||Targeted (Humanized sequence)|
|Allele Synonym(s)||Htttm1Mfc; targeted mutation 1, Marie-Francoise Chesselet|
|Gene Symbol and Name||Htt, huntingtin|
|Gene Synonym(s)||Hdh; C430023I11Rik; HD; AI256365; expressed sequence AI256365; RIKEN cDNA C430023I11 gene; Huntington disease (human); Huntington disease gene homolog; Hdh; Hd; IT15; C430023I11Rik; htt; Hd; LOMARS|
|Strain of Origin||129S1/Sv-Oca2+ Tyr+ Kitl+|
|Molecular Note||A fragment extending from 18 bp upstream of the polyglutamine stretch in exon 1 to 100 bp into intron 1 was replaced with human HD sequence containing 140 CAG repeats. A floxed neo cassette was retained 1.3 kb upstream of exon 1. Western blot analysis of homozygous mutant cerebellum and forebrain tissues identified protein corresponding with the mouse/human hybrid protein. Similar levels of mutant and endogenous protein were observed. The repeat number is not stable and may expand or contract.|
When maintaining our live colony, heterozygous mice are bred to C57BL/6J inbred mice (Stock No. 000664).
When using the B6J.CAG 140 KI ; B6J.CAG140 knock-in ; Q140 on C57BL/6J background ; CHDI-81003002 mouse strain in a publication, please cite the originating article(s) and include JAX stock #027409 in your Materials and Methods section.
|Heterozygous or wildtype for Htt<tm1Mfc>/|
We will fulfill your order by providing at least two carriers for each strain ordered. The total number, sex, and genotypes provided will vary, although typically 8 or more animals are provided. Please check genotypes which will be recovered. While the genotypes of all animals produced will be communicated to you prior to scheduling shipment, the genotypes of animals provided may not reflect the mating scheme and genotypes described in the strain description. Animals are typically ready to ship in 11-14 weeks. If a second recovery is required to produce the minimum number of animals, then delivery time would increase to approximately 25 weeks. If we fail to produce animals of the correct genotype, you will not be charged. We cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.
Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.